Natasha Rabaeijs_KT Annual Meeting 2019. Photo by Christian Ove Carlsson

A glimpse of a digitized future

One of the world’s largest pharmaceutical corporations, Glaxo SmithKline (GSK), researches, develops, and manufactures innovative medicines, vaccines, and consumer health care products.

“In my job at a manufacturing site, we are mainly reactive. So, some of the tools presented here, like the ICAS software for property prediction, are maybe more relevant to my colleagues in research and development. Still, these tools might also be useful for us for diagnostic purposes,” says Chemical Engineering Associate at GSK Natasha Rabaeijs.

One difference between the conference presentations and her daily work life has been striking to Natasha Rabaeijs:

“There is so much data available from the projects, we hear about. Given the equipment we currently have at our plant, this kind of extensive data collection is just not possible. But later, as our equipment gradually will be worn out and become replaced, I think this will also be a part of the future at a manufacturing site. By that time, we will have better use for software like ICAS. For instance, I find the functionality on azeotropes interesting.”

An azeotrope is a mixture of two or more liquids which, when boiled, will still have the same proportions of the constituents as the un-boiled mixture. This has huge practical implications, as it is not possible to separate the constituents by distillation. A functionality in ICAS provides the azeotropes of a given substance.

Natasha Rabaeijs attends the KT-Consortium annual meeting for her first time:

“It is the policy in GSK, that younger chemical engineering graduates like myself get the chance to attend this type of conferences. Obviously, I cannot bring as much to the table as can the more experienced colleagues here. But I like the atmosphere at the conference and just try to absorb as much knowledge as possible!”